BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 37947639)

  • 1. Leucine Supplementation Improves Diastolic Function in HFpEF by HDAC4 Inhibition.
    Alves PKN; Schauer A; Augstein A; Männel A; Barthel P; Joachim D; Friedrich J; Prieto ME; Moriscot AS; Linke A; Adams V
    Cells; 2023 Nov; 12(21):. PubMed ID: 37947639
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Leucine Supplementation Prevents the Development of Skeletal Muscle Dysfunction in a Rat Model of HFpEF.
    Alves PKN; Schauer A; Augstein A; Prieto Jarabo ME; Männel A; Barthel P; Vahle B; Moriscot AS; Linke A; Adams V
    Cells; 2024 Mar; 13(6):. PubMed ID: 38534346
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Empagliflozin Improves Diastolic Function in HFpEF by Restabilizing the Mitochondrial Respiratory Chain.
    Schauer A; Adams V; Kämmerer S; Langner E; Augstein A; Barthel P; Männel A; Fabig G; Alves PKN; Günscht M; El-Armouche A; Müller-Reichert T; Linke A; Winzer EB
    Circ Heart Fail; 2024 Jun; 17(6):e011107. PubMed ID: 38847102
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting MuRF1 by small molecules in a HFpEF rat model improves myocardial diastolic function and skeletal muscle contractility.
    Adams V; Schauer A; Augstein A; Kirchhoff V; Draskowski R; Jannasch A; Goto K; Lyall G; Männel A; Barthel P; Mangner N; Winzer EB; Linke A; Labeit S
    J Cachexia Sarcopenia Muscle; 2022 Jun; 13(3):1565-1581. PubMed ID: 35301823
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of homoarginine supplementation on heart and skeletal muscle of rats with heart failure with preserved ejection fraction.
    Büttner P; Adams V; Werner S; Ossmann S; Besler C; Schwedhelm E; Thiele H
    ESC Heart Fail; 2022 Dec; 9(6):4348-4351. PubMed ID: 36043453
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Both male and female obese ZSF1 rats develop cardiac dysfunction in obesity-induced heart failure with preserved ejection fraction.
    Nguyen ITN; Brandt MM; van de Wouw J; van Drie RWA; Wesseling M; Cramer MJ; de Jager SCA; Merkus D; Duncker DJ; Cheng C; Joles JA; Verhaar MC
    PLoS One; 2020; 15(5):e0232399. PubMed ID: 32374790
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adenosine Kinase Inhibition Augments Conducted Vasodilation and Prevents Left Ventricle Diastolic Dysfunction in Heart Failure With Preserved Ejection Fraction.
    Davila A; Tian Y; Czikora I; Li J; Su H; Huo Y; Patel V; Robinson V; Kapuku G; Weintraub N; Bagi Z
    Circ Heart Fail; 2019 Aug; 12(8):e005762. PubMed ID: 31525084
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of Triiodothyronine Treatment in an Animal Model of Heart Failure with Preserved Ejection Fraction.
    Neves JS; Leite AR; Conceição G; Gonçalves A; Borges-Canha M; Vale C; Von-Hafe M; Martins D; Miranda-Silva D; Leite S; Rocha-Oliveira E; Sousa-Mendes C; Chaves J; Lourenço IM; Grijota-Martínez C; Bárez-López S; Miranda IM; Almeida-Coelho J; Vasques-Nóvoa F; Carvalho D; Lourenço A; Falcão-Pires I; Leite-Moreira A
    Thyroid; 2023 Aug; 33(8):983-996. PubMed ID: 37140469
    [No Abstract]   [Full Text] [Related]  

  • 9. Renal injury in relation to obesity and the additive effect of hypertension in female and male obese and lean ZSF1 rats.
    Nguyen ITN; Cramer MJ; Joles JA; Verhaar MC
    Am J Physiol Renal Physiol; 2023 Jul; 325(1):F73-F86. PubMed ID: 37227224
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ZSF1 rat as animal model for HFpEF: Development of reduced diastolic function and skeletal muscle dysfunction.
    Schauer A; Draskowski R; Jannasch A; Kirchhoff V; Goto K; Männel A; Barthel P; Augstein A; Winzer E; Tugtekin M; Labeit S; Linke A; Adams V
    ESC Heart Fail; 2020 Oct; 7(5):2123-2134. PubMed ID: 32710530
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Telmisartan ameliorates cardiac fibrosis and diastolic function in cardiorenal heart failure with preserved ejection fraction.
    Chang D; Xu TT; Zhang SJ; Cai Y; Min SD; Zhao Z; Lu CQ; Wang YC; Ju S
    Exp Biol Med (Maywood); 2021 Dec; 246(23):2511-2521. PubMed ID: 34342551
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Histological and haemodynamic characterization of right ventricle in sedentary and trained rats with heart failure with preserved ejection fraction.
    Oliveira MI; Leite S; Barros A; Lourenço AP; Mendes C; Schmidt C; Santos M; Leite-Moreira A; Moreira-Gonçalves D
    Exp Physiol; 2021 Dec; 106(12):2457-2471. PubMed ID: 34676608
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Empagliflozin Preserves Skeletal Muscle Function in a HFpEF Rat Model.
    Winzer EB; Schauer A; Langner E; Augstein A; Goto K; Männel A; Barthel P; Jannasch A; Labeit S; Mangner N; Linke A; Adams V
    Int J Mol Sci; 2022 Sep; 23(19):. PubMed ID: 36232292
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute and chronic effects of levosimendan in the ZSF1 obese rat model of heart failure with preserved ejection fraction.
    Moreira-Costa L; Tavares-Silva M; Almeida-Coelho J; Gonçalves A; Trindade F; Vasques-Nóvoa F; Sousa-Mendes C; Leite S; Vitorino R; Falcão-Pires I; Leite-Moreira AF; Lourenço AP
    Eur J Pharmacol; 2024 Mar; 966():176336. PubMed ID: 38272343
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A directed network analysis of the cardiome identifies molecular pathways contributing to the development of HFpEF.
    Summer G; Kuhn AR; Munts C; Miranda-Silva D; Leite-Moreira AF; Lourenço AP; Heymans S; Falcão-Pires I; van Bilsen M
    J Mol Cell Cardiol; 2020 Jul; 144():66-75. PubMed ID: 32422321
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acetylation and phosphorylation changes to cardiac proteins in experimental HFpEF due to metabolic risk reveal targets for treatment.
    Koser F; Hobbach AJ; Abdellatif M; Herbst V; Türk C; Reinecke H; Krüger M; Sedej S; Linke WA
    Life Sci; 2022 Nov; 309():120998. PubMed ID: 36179815
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exercise Training Reveals Inflexibility of the Diaphragm in an Animal Model of Patients With Obesity-Driven Heart Failure With a Preserved Ejection Fraction.
    Bowen TS; Brauer D; Rolim NPL; Bækkerud FH; Kricke A; Ormbostad Berre AM; Fischer T; Linke A; da Silva GJ; Wisloff U; Adams V
    J Am Heart Assoc; 2017 Oct; 6(10):. PubMed ID: 29066440
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disturbed cardiac mitochondrial and cytosolic calcium handling in a metabolic risk-related rat model of heart failure with preserved ejection fraction.
    Miranda-Silva D; Wüst RCI; Conceição G; Gonçalves-Rodrigues P; Gonçalves N; Gonçalves A; Kuster DWD; Leite-Moreira AF; van der Velden J; de Sousa Beleza JM; Magalhães J; Stienen GJM; Falcão-Pires I
    Acta Physiol (Oxf); 2020 Mar; 228(3):e13378. PubMed ID: 31520455
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Myocardial Microvascular Inflammatory Endothelial Activation in Heart Failure With Preserved Ejection Fraction.
    Franssen C; Chen S; Unger A; Korkmaz HI; De Keulenaer GW; Tschöpe C; Leite-Moreira AF; Musters R; Niessen HW; Linke WA; Paulus WJ; Hamdani N
    JACC Heart Fail; 2016 Apr; 4(4):312-24. PubMed ID: 26682792
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiac diastolic and autonomic dysfunction are aggravated by central chemoreflex activation in heart failure with preserved ejection fraction rats.
    Toledo C; Andrade DC; Lucero C; Arce-Alvarez A; Díaz HS; Aliaga V; Schultz HD; Marcus NJ; Manríquez M; Faúndez M; Del Rio R
    J Physiol; 2017 Apr; 595(8):2479-2495. PubMed ID: 28181258
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.